Plan to elect KPMA head hits snag

Published: 2010-03-09 07:00:00

Updated: 2010-03-09 07:00:00

The Korea Pharmaceutical Manufacturers Association, the business lobby group, says its plan to elect a president of its newly established 7-memeber emergency committee is expected to be delayed for the time being.

Sources say the major reason is that leading candidates in the association have ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK